HIV latency reversing agents act through Tat post translational modifications

Georges Khoury; Talia M Mota; Shuang Li; Carolin Tumpach; Michelle Y Lee; Jonathan Jacobson; Leigh Harty; Jenny L Anderson; Sharon R Lewin; Damian FJ Purcell

Journal article

HIV latency reversing agents act through Tat post translational modifications

Georges Khoury, Talia M Mota, Shuang Li, Carolin Tumpach, Michelle Y Lee, Jonathan Jacobson, Leigh Harty, Jenny L Anderson, Sharon R Lewin, Damian FJ Purcell

RETROVIROLOGY | BMC | Published : 2018

DOI: 10.1186/s12977-018-0421-6

Download PDF

University of Melbourne Researchers

Sharon Lewin Author Doherty Institute

Damian Purcell Author Microbiology and Immunology

Related Projects (3)

THE FUTURE OF HIV CARE - LONG TERM REMISSION AND ELIMINATING CO-MORBIDITIES

Despite the great successes in antiretroviral therapy (ART) in reducing HIV-associated mortality, treatment is life long and there is no cur..

IMPROVED HEALTH OUTCOMES FOR PEOPLE LIVING WITH HIV

Despite the success of antiviral therapy for HIV infection, HIV cannot be cured and treatment is life long. In addition, there are complicat..

RNA PROCESSING MECHANISMS CONTROLLING HIV LATENCY

Successful HIV remission and cure, where patients can live normally without daily drug therapy and risk of transmitting infectious virus, wi..

Grants

Awarded by NHMRC of Australia

Awarded by National Institutes for Health Delaney AIDS Research Enterprise

Funding Acknowledgements

This work was supported by project grant APP1129320, and program grant APP1052979 from the NHMRC of Australia. SRL is an NHMRC practitioner fellow and is supported by the National Institutes for Health Delaney AIDS Research Enterprise (DARE U19 AI096109), and the American Foundation for AIDS Research.